95 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
not been disclosed therein, and (C) if elected as a Director, will comply with all applicable corporate governance, conflict of interest
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
Act") regarding universal proxy cards, changes to the Delaware General Corporation Law (the "DGCL"), and a periodic review of corporate governance
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
(A) the Administrative Agent shall be authorized to form one or more acquisition vehicles to make a bid, (B) to adopt documents providing for the governance
8-K
hwkmt
27 Sep 23
Departure of Directors or Certain Officers
8:38am
8-K
4xr wypntr
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
425
4h7jolrlmo828
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
2kjjo26gkvs7nnl948i
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
bq9o5r7b5jii21
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K
EX-3.1
mlv6wmi0 bd
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm